<DOC>
	<DOCNO>NCT00662870</DOCNO>
	<brief_summary>This study design ass lot comparability DAPTACEL , well safety immunogenicity DAPTACEL co-administered recommend infant vaccine . Stage I Primary Objectives : 1 . To assess lot-comparability immunogenicity DAPTACEL co-administered recommend vaccine . 2 . To compare immune response DTaP-IPV/Hib ( Pentacel ) three lot DAPTACEL co-administered recommend vaccine . 3 . To compare immune response PRP-T antigen Pentacel ActHIB concurrently administer different injection site DAPTACEL vaccines co-administered recommended vaccine . Stage II Primary Objectives : 1 . To compare immune response DAPTACEL 4th dose co-administered Hib infant vaccine . 2 . To compare immune response Pentacel elicit DAPTACEL co-administered ActHIB toddler .</brief_summary>
	<brief_title>Study Safety , Immunogenicity Lot Comparability DAPTACEL When Administered With Other Recommended Vaccine</brief_title>
	<detailed_description>This two-stage , randomize , multi-center study ass safety , immunogenicity lot comparability DAPTACEL</detailed_description>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Tetany</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion Criteria : Healthy infant 2 month age . Infants least 37 week gestation delivery . Signed informed consent parent guardian . Able attend schedule visit comply study procedure . Subjects must receive first dose hepatitis B vaccine birth 28 day prior first dose DAPTACEL Pentacel . Exclusion Criteria : Clinically significant finding review system physical examination ( determined investigator subinvestigator sufficient exclusion ) . Known suspected hypersensitivity component study vaccine administer . Known suspected impairment immunologic function receipt immunosuppressive therapy immunoglobulin since birth . Known HIVpositive mother . Personal immediate family history congenital immune deficiency . Developmental delay neurologic disorder . Chronic medical , congenital , developmental surgical disease . Participation experimental vaccine trial . Any condition , opinion investigator subinvestigator , would interfere evaluation vaccine pose health risk subject . Prior history receive one dose hepatitis B vaccine , diphtheria , tetanus acellular pertussis combination vaccine ( DTaP ) , diphtheria , tetanus wholecell pertussis combination vaccine ( DTwP ) , Haemophilus influenzae type b ( Hib ) conjugate vaccine , poliovirus vaccine pneumococcal conjugate vaccine</criteria>
	<gender>All</gender>
	<minimum_age>42 Days</minimum_age>
	<maximum_age>84 Days</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>DAPTACEL</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Whooping Cough</keyword>
	<keyword>Polio</keyword>
	<keyword>Haemophilus influenzae type b</keyword>
	<keyword>Pertussis</keyword>
</DOC>